Abstract:To investigate changes in human leucocyte antigen (HLA)-DR expression on peripheral monocytes, determine the value of predicting the development of stroke-associated infection (SAI), and determine the correlation with other conditions in critically-ill patients in the neurological intensive care unit (NICU) who suffered an acute stroke.All patients were enrolled consecutively and admitted to NICU within 24 h after the onset of symptoms. Patients were followed in order to identify whether infection developed and determine survival status within 2 weeks after the stroke. Patients were divided into stroke or control group by study design, infection or non-infection group by whether or not they had an infection, survival or death group by prognosis and cerebral infarction or cerebral haemorrhage group by stroke type. Patients in which acute stroke was excluded by head CT or MRI were admitted to general ward and were used as a control group. Blood samples were collected serially on days 1, 2, 4, 6 and 14 after stroke, then monocyte human leucocyte antigen-DR (HLA-DR) expression was determined by flow cytometry. The National Institute of Health Stroke Scale (NIHSS), Acute Physiology and Chronic Health Evaluation II (APACHEII) and Glasgow Coma Scale (GCS) scores were recorded over the course of observation.Fifty-three subjects and 39 controls were enrolled in the study. On days 1, 2, 4, 6 and 14, there was a significant difference in monocyte HLA-DR expression between stroke group and control group (all P < 0.001), but no difference was found between ischaemic stroke group and haemorrhagic stroke group (all P > 0.05). The infection group compared with non-infection group did not exhibit a significant difference in HLA-DR expression on days 1 and 2 (all P > 0.05), but significant differences emerged on days 4, 6 and 14 (all P < 0.01). On days 1 and 2 the HLA-DR expression in the survival group compared with death group, was not significantly different (all P > 0.05), but differences became significant on days 4 and 6 (P < 0.01). On day 1, HLA-DR expression < 62.80% had the predictive value to SAI (sensitivity 83.3%, specificity 55.2%, AUC = 0.661, P = 0.031) and on day 2, HLA-DR expression < 57.83% had the predictive value to SAI (sensitivity 95.8%, specificity 79.3%, AUC = 0.907, P = 0.000) in acute stroke patients. A statistically significant inverse correlation was found between NIHSS and HLA-DR on days 2 and 4 during the observation period (all P < 0.01), but there was no statistically significant negative correlation on days 1, 6 or 14 (all P > 0.05). HLA-DR expression did not correlate with APACHEII (all P > 0.05) or GCS (all P > 0.05) during the measurement period.Human leucocyte antigen-DR (HLA-DR) expression decreases and sustains a dynamic change and it also relates to the severity of patient's condition in the critically-ill patients with stroke. Progressively persistent low monocyte HLA-DR expression is associated with a poor prognosis. The decline in HLA-DR expression contributes to infection in critically-acute stroke patients. Monitoring of monocyte HLA-DR expression may be useful for identifying patients suffering from acute stroke who are at high risk for infection.

Monocyte human leukocyte antigen-DR expression in trauma patients and its clinical significance

Dynamic Changes of Circulating T-Helper Cell Subsets Following Severe Thoracic Trauma

Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma

A Decrease of Human Leucocyte Antigen‐dr Expression on Monocytes in Peripheral Blood Predicts Stroke‐associated Infection in Critically‐ill Patients with Acute Stroke

Monocyte human leukocyte antigen-DR expression and the prognosis in patients with acute respiratory distress syndrome

Study on the Relationship Between the Human Leucocyte Antigen-Dr Expression on CD14~+ Monocytes and Sepsis

Influence of Intensive Insulin Therapy on Rate of CD14+ and Expression of CD14+ Monocyte Human Leukocyte Antigen DR in Severe Trauma Patients

Altered Immune Function Of Monocytes In Different Stages Of Patients With Acute On Chronic Liver Failure

Changes of Monocyte Human Leukocyte Antigen-Dr Expression As a Reliable Predictor of Mortality in Severe Sepsis.

Expression Of Monocyte Hla-Dr And Blood Lactic Acid Level In Patients With Sepsis And Correlation With Prognosis

Mononuclear histocompatibility leukocyte antigen-DR expression in the early phase of acute pancreatitis.

Decreased Monocyte HLA-DR Expression in Patients After Non-Shockable out-of-Hospital Cardiac Arrest

The effect of cardiopulmonary bypass on monocyte HLA-DR expression

Changes of Toll-like receptor 4 in the patients with acute lung injury induced by trauma and its clinical significance

Low HLA-DR Expression on CD14+ Monocytes of Burn Victims with Sepsis, and the Effect of Carbachol in Vitro.

Correlations Between Monocyte Immunosuppression and the Inflammatory Markers in Patients with Severe Acute Stroke

Expression of CD14 + HLA-DRlow/- Monocytes in Peripheral Blood of Patients with Non-Hodgkin Lymphoma and Its Significance

Clinical Significance of Changes in Quantitative Expression of Human Leukocyte Antigen DR in Severely Burned Patients

Clinical Significance of Shift of Plasma IFN-γ、IL-4 Cytokines in Patients after Trauma

Monitor the level of HLA-DR of peripheral blood CD14+monocyte dynamically to predict the prognosis of patients with severe pneumonia

Human Leukocyte Antigen-Dr Expression on Peripheral Monocytes May Be an Early Marker for Secondary Infection in Severe Acute Pancreatitis.